Will Jupiter Wellness’ Innovative New Product Sway Investors?

Tuesday, April 5, 2022 marked a momentous day for Jupiter Wellness (NASDAQ:JUPW) as they announced the launch of their groundbreaking proprietary line of innovative sunscreen, NoStingz.

Investors will be watching closely to see if Jupiter Wellness stock is investment-worthy following the new product launch. Jupiter Wellness stock could move depending on NoStingz long-term availability, market acceptance and overall success. 

Read more to learn more about NoStingz, other Jupiter Wellness news and potential effects on Jupiter Wellness’ share price.

What is NoStingz?

NoStingz is a new product in Jupiter Wellness’s proprietary sunscreen line designed to protect users against jellyfish and man o’ war stings, sea lice, and swimmer’s itch. In addition, it also protects ocean lovers’ skin from harmful UVA/UVB in a range of SPFs.

Jupiter Wellness developed NoStingz as part of its partnership with Shark Defense Technologies LLC. The agreement gives Jupiter Wellness exclusive worldwide intellectual property rights to Shark Defense Technologies formulas and production methods for jellyfish protective compounds. It also guarantees future collaborations between both companies to develop and refine additional formulas. 

NoStingz is especially important for global ocean lovers, beach-goers and tourists who would otherwise face physical danger due to Jellyfish and other common sea creatures. The U.S. National Foundation estimates that 150 million people get stung by jellyfish yearly. About 200,000 of those stings occur in Florida. In addition, scientists believe there is an increasing number of jellyfish each year, meaning more bites and stings for future swimmers. 

A jellyfish’s sting can cause intense pain, swelling, itching, and tentacle print marks. These notorious stings can also lead to breathing difficulties and potentially fatal heart problems.

NoStingz was designed to provide a reliable line of defense, and potentially save hundreds of lives each year. The product line includes sprays and lotion for kids and adults, with more SKUs to be added. NoStingz’s dermatologically tested, hypoallergenic, scientifically proven, waterproof formula prevents stings from most jellyfish and sea lice. It also gives sunray and UV protection and comes packaged in a biodegradable bottle that is harmless to the marine environment.

Is Jupiter Wellness a buy following NoStingz’s launch? 

The future looks bright for Jupiter Wellness following its partnership with Shark Defense Technologies LLC. 

The partnership is already becoming fruitful. Besides the launch of NoStringz, Jupiter Wellness also launched CaniSun for Shark Defense Sunscreen, a product that will protect ocean lovers from unprovoked shark attacks. Undoubtedly, even more products are on the horizon, helping Jupiter Wellness rally revenue gains in the coming year. 

Investors are also optimistic about the rise of the global sun care market. Worth $13 billion in 2019 and estimated to rise to $17 billion by 2027, the global sun care market is steadily growing. Investors willing to buy and hold pioneering companies in the suncare industry could reap large rewards on their investments in the coming years. 

Conclusion

As of 10:17 AM EDT on Monday, April 19, 2022, Jupiter Wellness was trading at $1.0350, up by 1.47% from its previous close of $1.02 per share. The company’s market capitalization is $23.189 million. 

Jupiter Wellness has announced plans to continuously expand its market reach and revenue share of the global suncare, CBD and other wellness industries through innovative product launches like NoStingz. Jupiter Wellness looks well on course for an increase in its share price and stock market portfolio in 2022-2023 as it continues to develop innovative products and strike strategic partnerships.

Want to learn more about Jupiter Wellness and see if we think it’s a buy? Click here to read our JUPW stock review and alert page. 

Beat The Market With Our Expert Stock Picks

If you invested in 10 of our featured stock picks over the last 5 years, your chances of beating the market would be 90%.

Our last 3 stock picks grew a combined 348% after our alert!

Want to be notified the next time we issue a “Big Buy” alert or update our stocks to buy list? Sign up below today.

Disclaimer: Nothing on this website should be considered personalized financial advice. Any investments recommended here in should be made only after consulting with your personal investment advisor and only after performing your own research and due diligence, including reviewing the prospectus or financial statements of the issuer of any security.